COSENTYX
- Product NDC
- 0078-1168
- 11-digit product format
- 000781168
- Labeler code
- 0078
- Product ID
- 0078-1168_ecc0059c-d566-4830-b4c1-35535c9ecca2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- secukinumab
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Labeler
- Novartis Pharmaceuticals Corporation
- Application
- BLA761349
- Marketing category
- BLA
- Marketing start
- 2023-10-06
- Substance
- SECUKINUMAB
- Active strength
- 25 mg/mL
- Pharmacologic classes
- Interleukin-17A Antagonist [EPC], Interleukin-17A Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data
- Finished product
- Yes
- Brand name base
- COSENTYX
- Listing expiration
- 2027-12-31
Active Ingredients
| Ingredient | Strength |
|---|
| SECUKINUMAB | 25 mg/mL |
Harmonized Identifiers
| Field | Values |
|---|
| Unii | DLG4EML025 |
| Rxcui | 1599792, 1599797, 1653241, 1653243, 2550712, 2550713, 2637347, 2637348, 2667419, 2667423 |
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| DLG4EML025 | SECUKINUMAB | 1229022-83-6 | SECUKINUMAB |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 0078-1168-61 | 00078116861 | 5 mL in 1 VIAL, GLASS (0078-1168-61) | 5 ml | 2023-10-06 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| COSENTYX | Novartis Pharmaceuticals Corporation | 2026-04-17 | HUMAN PRESCRIPTION DRUG LABEL | 29 |